Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Machida

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
International Journal of Radiation Oncology, Biology, Physics|September 7, 2000
Target volume definition for upper abdominal irradiation using CT scans obtained during inhale and exhale phasesT Aruga, J Itami, M Aruga, et al.
Journal of the American Geriatrics Society|November 5, 1997
Effect of genetic risk factors and disease progression on the cerebrospinal fluid tau levels in Alzheimer's diseaseH Arai, M Terajima, M Miura, et al.
Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica|August 26, 1998
[Bleomycin, adriamycin, cyclophosphamide, vincristine, deacadron, etoposide (BACOD-E) chemotherapy for the treatment of non-Hodgkin's lymphoma: long-term survival rate and complications]K Isobe, S Yasuda, J Itami, et al.
The American Journal of Physiology|August 1, 1997
Volume-overload cardiac hypertrophy is unaffected by ACE inhibitor treatment in dogsL J Dell'italia, E Balcells, Q C Meng, et al.
ESMO Open|June 13, 2021
Impact of tumor growth rate during preceding treatment on tumor response to nivolumab or irinotecan in advanced gastric cancerK Kato, T Masuishi, K Fushiki, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 28, 2000
Treatment for pyothorax-associated lymphomaT Aruga, J Itami, K Nakajima, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Prognostic factors for overall survival in advanced digestive neuroendocrine carcinoma treated with first-line cisplatin-based chemotherapy: a <i>post hoc</i> analysis of JCOG1213H Hirano, K Hirata, Y Honma, et al.
ESMO Open|October 31, 2025
FGFR2-IIIc isoform detection reveals prognostic prevalence and a functional link to mesenchymal transition in gastric and gastroesophageal junction cancerT Hashimoto, N Iida, S Kadowaki, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
International Journal of Radiation Oncology, Biology, Physics|September 7, 2000
Target volume definition for upper abdominal irradiation using CT scans obtained during inhale and exhale phasesT Aruga, J Itami, M Aruga, et al.
Journal of the American Geriatrics Society|November 5, 1997
Effect of genetic risk factors and disease progression on the cerebrospinal fluid tau levels in Alzheimer's diseaseH Arai, M Terajima, M Miura, et al.
Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica|August 26, 1998
[Bleomycin, adriamycin, cyclophosphamide, vincristine, deacadron, etoposide (BACOD-E) chemotherapy for the treatment of non-Hodgkin's lymphoma: long-term survival rate and complications]K Isobe, S Yasuda, J Itami, et al.
The American Journal of Physiology|August 1, 1997
Volume-overload cardiac hypertrophy is unaffected by ACE inhibitor treatment in dogsL J Dell'italia, E Balcells, Q C Meng, et al.
ESMO Open|June 13, 2021
Impact of tumor growth rate during preceding treatment on tumor response to nivolumab or irinotecan in advanced gastric cancerK Kato, T Masuishi, K Fushiki, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 28, 2000
Treatment for pyothorax-associated lymphomaT Aruga, J Itami, K Nakajima, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Prognostic factors for overall survival in advanced digestive neuroendocrine carcinoma treated with first-line cisplatin-based chemotherapy: a <i>post hoc</i> analysis of JCOG1213H Hirano, K Hirata, Y Honma, et al.
ESMO Open|October 31, 2025
FGFR2-IIIc isoform detection reveals prognostic prevalence and a functional link to mesenchymal transition in gastric and gastroesophageal junction cancerT Hashimoto, N Iida, S Kadowaki, et al.
Pageof 8